(1R,5S,8R,9S,12R,14R)-8,12-dimethyl-4-[[(1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one

C25H39NO3 — CID 146170688

IUPAC(1R,5S,8R,9S,12R,14R)-8,12-dimethyl-4-[[(1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one
SMILESC[C@@H]1CC[C@H]2C(CN3C[C@]4(C)C[C@H]3CC(C)(C)C4)C(=O)O[C@]23[C@H]1CC[C@@]1(C)O[C@@H]31
InChIInChI=1S/C25H39NO3/c1-15-6-7-19-17(12-26-14-23(4)11-16(26)10-22(2,3)13-23)20(27)28-25(19)18(15)8-9-24(5)21(25)29-24/h15-19,21H,6-14H2,1-5H3/t15-,16-,17?,18+,19+,21-,23-,24-,25-/m1/s1
InChIKeySTFFSDASJHIJJV-PUCXFWDSSA-N
MW401.59 g/mol
LogP4.41
Rot. Bonds2

About (1R,5S,8R,9S,12R,14R)-8,12-dimethyl-4-[[(1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one

(1R,5S,8R,9S,12R,14R)-8,12-dimethyl-4-[[(1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one (PubChem CID 146170688) has the molecular formula C25H39NO3 and a molecular weight of 401.59 g/mol. Its IUPAC name is (1R,5S,8R,9S,12R,14R)-8,12-dimethyl-4-[[(1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one.

Molecular Properties

Compound Name(1R,5S,8R,9S,12R,14R)-8,12-dimethyl-4-[[(1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one
PubChem CID146170688
Molecular FormulaC25H39NO3
Molecular Weight401.59 g/mol
Exact Mass401.29
IUPAC Name(1R,5S,8R,9S,12R,14R)-8,12-dimethyl-4-[[(1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one
SMILESC[C@@H]1CC[C@H]2C(CN3C[C@]4(C)C[C@H]3CC(C)(C)C4)C(=O)O[C@]23[C@H]1CC[C@@]1(C)O[C@@H]31
InChIInChI=1S/C25H39NO3/c1-15-6-7-19-17(12-26-14-23(4)11-16(26)10-22(2,3)13-23)20(27)28-25(19)18(15)8-9-24(5)21(25)29-24/h15-19,21H,6-14H2,1-5H3/t15-,16-,17?,18+,19+,21-,23-,24-,25-/m1/s1
InChIKeySTFFSDASJHIJJV-PUCXFWDSSA-N
XLogP4.41
TPSA42.07 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds2
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500401.59
LogP ≤ 54.41
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'}

Analyze (1R,5S,8R,9S,12R,14R)-8,12-dimethyl-4-[[(1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,5S,8R,9S,12R,14R)-8,12-dimethyl-4-[[(1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one?
The IUPAC name of (1R,5S,8R,9S,12R,14R)-8,12-dimethyl-4-[[(1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one (CID 146170688) is (1R,5S,8R,9S,12R,14R)-8,12-dimethyl-4-[[(1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one.
What is the SMILES notation for (1R,5S,8R,9S,12R,14R)-8,12-dimethyl-4-[[(1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one?
The canonical SMILES for (1R,5S,8R,9S,12R,14R)-8,12-dimethyl-4-[[(1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one is C[C@@H]1CC[C@H]2C(CN3C[C@]4(C)C[C@H]3CC(C)(C)C4)C(=O)O[C@]23[C@H]1CC[C@@]1(C)O[C@@H]31.
What is the InChIKey of (1R,5S,8R,9S,12R,14R)-8,12-dimethyl-4-[[(1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one?
The InChIKey is STFFSDASJHIJJV-PUCXFWDSSA-N. The full InChI is InChI=1S/C25H39NO3/c1-15-6-7-19-17(12-26-14-23(4)11-16(26)10-22(2,3)13-23)20(27)28-25(19)18(15)8-9-24(5)21(25)29-24/h15-19,21H,6-14H2,1-5H3/t15-,16-,17?,18+,19+,21-,23-,24-,25-/m1/s1.
What are the key properties of (1R,5S,8R,9S,12R,14R)-8,12-dimethyl-4-[[(1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one?
(1R,5S,8R,9S,12R,14R)-8,12-dimethyl-4-[[(1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one has a molecular weight of 401.59 g/mol, XLogP of 4.41, 2 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,5S,8R,9S,12R,14R)-8,12-dimethyl-4-[[(1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one is sourced from PubChem (CID 146170688), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).